Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vitamin D receptor polymorphism and breast cancer risk.
Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Newcomb PA, et al. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1503-4. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433736 No abstract available.
Parity and the risk of Down's syndrome.
Doria-Rose VP, Kim HS, Augustine ET, Edwards KL. Doria-Rose VP, et al. Among authors: kim hs. Am J Epidemiol. 2003 Sep 15;158(6):503-8. doi: 10.1093/aje/kwg193. Am J Epidemiol. 2003. PMID: 12965874
Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis.
Yap J, Hayashida K, Lee MKY, Stub D, Hon JKF, Ho KW, Lo S, Seth A, Kim HS, Wongpraparut N, Nguyen QN, Dy TC, Chandavimol M, Ewe SH, Yin WH, Lee YT, Tay EL, Poon K, Chen M, Chui A, Lam SC, Rao RS, Izumo M, Nair R, Tang GH, Tabata M, Yahaya SA, Sin KY, Park DW, Wang J, Chieh JTW. Yap J, et al. Among authors: kim hs. JACC Asia. 2024 Nov 1;4(12):885-897. doi: 10.1016/j.jacasi.2024.10.001. eCollection 2024 Dec. JACC Asia. 2024. PMID: 39802986 Free PMC article.
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Oaknin A, Monk BJ, de Melo AC, Kim HS, Kim YM, Lisyanskaya AS, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin E, Takahashi S, Ramone D, Maćkowiak-Matejczyk B, Polastro L, Alia EMG, Colombo N, Makarova Y, Goh JC, Hasegawa K, Mora P, Pikiel J, Srivastav R, Rischin D, Rubio MJ, Perez J, Yoo SY, Gao B, Jamil S, Seebach F, Lowy I, Mathias M, Fury MG, Tewari KS. Oaknin A, et al. Among authors: kim hs. Eur J Cancer. 2025 Jan 10;216:115146. doi: 10.1016/j.ejca.2024.115146. Online ahead of print. Eur J Cancer. 2025. PMID: 39798514
16,202 results
You have reached the last available page of results. Please see the User Guide for more information.